Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis.
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study
Episode 33 with Dr. Pierre-Antoine Gourraud on the role of human leukocyte antigen in MS
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Microglia in health and disease.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
The use of hematopoietic stem cells in autoimmune diseases.
Biogen Idec receives notification of PDUFA date extension
You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients with Relapsing-Remitting Multiple Sclerosis.
Neuroscience: Improving Translation of Animal Models for Nervous System Disorders: A Workshop
CCL genes in multiple sclerosis and systemic lupus erythematosus.
ASNI Calgary 2015
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.

Pages